Radient Pharmaceuticals Corp
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jan 2011 | $8 M | No. 2 | $2 to $10 million | debt, options | SEC | |
| Mar 2010 | $11 M | No. 1 | $10 to $50 million | debt, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Radient Pharmaceuticals Corp had no revenue when it filed its newest notice of a funding round (Feb 2011).
SEC Form D (revenue range) · Feb 2011
Revenue range over time, as stated in its notices: revenue between $5 million and $25 million in 2010; no revenue in 2011.
SEC Form D (revenue range) · Feb 2011
The industry group it chose in its notices: Other.
SEC Form D · Feb 2011
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Radient Pharmaceuticals Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 36 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Akio Ariura | CFO | Feb 2011 |
| Douglas MacLellan | Executive officer | Feb 2011 |
| Akio C. Ariura | Executive officer | Apr 2010 |
| Douglas C. MacLellan | Executive officer | Apr 2010 |
| Douglas MacLellan | Director | Feb 2011 |
| Michael Boswell | Director | Feb 2011 |
| Minghui Jia | Director | Feb 2011 |
| Robert Beart | Director | Feb 2011 |
| Akio C. Ariura | Director | Apr 2010 |
| Douglas C. MacLellan | Director | Apr 2010 |
| Minghui (Henry) r Jia | Director | Apr 2010 |
| edward r arquilla | Director | Apr 2010 |
| michael r boswell | Director | Apr 2010 |
| william m. thompson | Director | Apr 2010 |